17 results
Summary of the therapeutic uses of adrenergic agonists
Table of Catecholamine Pressors, Non-Catecholamines, Alpha and Beta Receptor
Summary of the therapeutic ... of adrenergic agonists ... Table of Catecholamine ... Therapeutic Uses #Pharmacology ... #Alpha #Beta #Table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Medications #Pharmacology ... #Dosing #Dosing ... Impairment #CKD #Table
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Summary of characteristics ... AntiPlatelet #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions #Pharmacology ... #Cardiology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Summary of characteristics ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy #Table
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... #HalfLife #Dosing ... Thiazide #CHF #Cardiology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... #Pharmacology #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... GLP-I receptor agonist ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Summary of actions ... some Cholinergic Agonists ... Produces miosis during ... #Pharmacology # ... Table #Summary
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #medications #table ... #decisionaid #cardiology ... hematology #warfarin #dosing
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... Dosing: 3 mg ... oral route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology